Why we don't become immune to colds

Why we don’t become immune to colds

A team of researchers at the MedUni Vienna has discovered why we never become immune to colds, and why we are able to keep catching them: the MedUni Vienna study, published in The FASEB Journal in the USA by Katarzyna Niespodziana from the Institute of Pathophysiology and Allergy Research, shows that the human immune response to the rhinovirus is misdirected.

Scientists have discovered that the immune response to viruses targets the wrong part of the : the immune response attacks the inside of the virus cell and not the envelope, which is what the virus uses to become established in the patient’s mucosal tissue. “Anyone who has a cold develops antibodies against the wrong part of the virus, so their immune response fails to protect them. It 'misfires',” explains Rudolf Valenta, head of the research from the University Department of and Allergy Research at the MedUni Vienna. This could be the reason why humans cannot become immune to colds in the same way as they do with other infectious diseases, such as measles. When someone develops another cold, the antibodies once again attack the wrong part of the virus.

This finding is expected now to contribute to the development of antibody tests that previously were not available for colds, and an effective vaccine against colds, which can trigger asthma attacks. Research in this field is currently taking place as part of the EU “Predicta” project (www.predicta.eu), which the researchers in Vienna are also involved with. Says Valenta:  “Our role is not to fight colds per se. Much rather, we want to prevent patients with colds from becoming patients with exacerbated asthma.”

More information: The Journal of the Federation of American Societies for Experimental Biology (The FASEB Journal), “Misdirected antibody responses against an N-terminal epitope on human rhinovirus VP1 as explanation for recurrent RV infections.” K. Niespodziana, et al. FASEB J. 2011 Nov 25.

Provided by Medical University of Vienna

5 /5 (2 votes)
add to favorites email to friend print save as pdf

Related Stories

Immune suppression through cyclic plant peptides

Mar 01, 2012

A team of researchers at the MedUni Vienna, together with scientists from the University Hospital of Freiburg, has decoded a mechanism in cyclic plant peptides, known as cyclotides, from the family of coffee ...

Mechanism for more efficient cancer treatment decoded

Jan 19, 2012

(Medical Xpress) -- A research team from the Institute for Cancer Research at the MedUni Vienna has decoded a previously unknown mechanism of the active ingredient imiquimod in tumour defence. They have been ...

What does my child's sneeze mean?

Apr 26, 2011

(Medical Xpress) -- Though much of the beauty of spring is its vivid colors, rosy-red eyes and noses aren’t usually considered a welcome part of the landscape. Runny noses, sneezing and coughing often trumpet spring’s ...

Immunity to the common cold virus: sex and age matter

Jun 23, 2011

Researchers in the UQ School of Medicine at Princess Alexandra Hospital have made an important discovery about how the immune system reacts to rhinoviruses, the viruses that usually cause the common cold.

Recommended for you

Expelled DNA that traps toxins may backfire in obese

9 hours ago

(Medical Xpress)—The body's most powerful immune cells may have a radical way of catching their prey that could backfire on people who are overweight and others at risk for cancer, diabetes and chronic ...

Managing seasonal allergies

22 hours ago

(HealthDay)—Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.

Researchers investigating the mystery of a tiny 'sin'

Jun 13, 2013

When a strain of bacteria invades a human body, the immune system responds by generating antibodies to neutralize the threat. However, during subsequent infections by a similar bacterium, the immune system ...

Herpes virus exploits immune response to bolster infection

Jun 06, 2013

Researchers at the University of California, San Diego School of Medicine and colleagues report that the herpes simplex virus type-1 (HSV-1), which affects an estimated 50 to 80 percent of all American adults, exploits an ...

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...

Study evaluates procedures for diagnosing sarcoidosis

Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic ...